CD4 and diabetes mellitus: Our results demonstrated diabetes augments Th1 and Th17 response in EAMG rats, which is in line with previous observations that CD4+ T-cell-derived IFN‐γ and IL-17 were increased in diabetic settings both in human and animal models.